JUNS Earnings Date: Dec 2, 2026 (Estimated) — Jupiter Neurosciences, Inc.
NASDAQ
Updated
When is JUNS's next earnings date?
Jupiter Neurosciences, Inc. (JUNS) is expected to report Q3 2026 earnings on Wednesday, December 2, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$3.75 on revenue of $602,000.
How did JUNS do in its last earnings report?
In its most recent report on Aug 14, 2026 (Q2 2026), Jupiter Neurosciences, Inc. posted EPS of -$4.08 versus the -$3.75 estimate, a miss of 8.8%. Revenue was $24,245 against a $400,000 estimate. The stock's 1-day post-earnings move was -12.7%.
How much does JUNS stock move after earnings?
JUNS beat EPS estimates in 0 of its last 5 reported quarters. Over the last 6 reports the stock moved an average of 5.2% (up or down) in the day after earnings.
About Jupiter Neurosciences, Inc.
Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in clinical-stage research and development. Its primary focus is on advancing a resveratrol-based platform product, with the main objective of addressing neuro-inflammation. The company's pipeline includes several drug candidates: JNS101 is undergoing Phase II trials for Friedreich's Ataxia, a rare neurological disorder that damages the nervous system and causes mobility issues. Also in Phase II, JNS102 is being developed for mucopolysaccharidosis Type I, JNS107 for MELAS Syndrome, and JNS108 for mild cognitive impairment and early Alzheimer's disease. Furthermore, the company is progressing JNS109 for amyotrophic lateral sclerosis, JNS110 for traumatic brain injury and concussion, and JNS120 as a treatment for COVID-19. Founded in 2016, the company, formerly known as Jupiter Orphan Therapeutics, Inc., adopted its current name in August 2021 and is headquartered in Jupiter, Florida.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-14 | Q2 2026 | -3.75 | -4.08 | -8.80% | $24,245 | ❌ Miss | -12.67% | -13.83% | -43.17% |
| 2026-05-14 | Q1 2026 | -0.05 | -0.06 | -20.00% | $18,652 | ❌ Miss | -3.28% | -22.51% | -32.62% |
| 2026-04-01 | Q4 2025 | -0.06 | -0.07 | -16.67% | $21,796 | ❌ Miss | -2.91% | +0.95% | +2.70% |
| 2025-11-14 | Q3 2025 | -0.02 | -0.07 | -250.00% | $0 | ❌ Miss | -5.22% | -11.94% | -14.18% |
| 2025-08-19 | Q2 2025 | -0.07 | -0.07 | +0.00% | $0 | ➖ Inline | +4.03% | +16.13% | +20.16% |
| 2024-12-23 | Q3 2024 | — | -0.02 | — | $0 | — | +3.38% | -2.28% | -89.04% |
Showing last 6 quarters.